Noom Med vs Willow

Both sell tirzepatide. Noom Med costs $149 a month and Willow costs $399, a difference of $250 a month or about $3,000 a year. The desk reads it as follows.

Noom Med is behaviour change alongside medication. Willow is straightforward single-price plans. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Noom Med advertises $149 and bills $149; Willow advertises $399 and bills $399. Both gaps are the same size, so the advertised comparison happens to hold.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

They differ on 1 of the 7 things we track, and behave the same on the other 6. The differences are what the price gap is actually buying.

What each puts on the record: Noom Med

• Noom Med listed from $149/month.
• Microdose GLP-1Rx programme listed from $79/month with medication included.
• Programme pairs low-dose medication with biomarker monitoring and coaching.

Where it wins: The coaching is the actual product here and it is well built. Watch for: A $79 microdose programme is not the same treatment as 10 mg tirzepatide. Check the dose before comparing on price.

What each puts on the record: Willow

• Compounded tirzepatide listed at $399/month.

Where it wins: A single price with no membership arithmetic. Watch for: There is little published detail on how dose changes are handled. Ask before committing.

In each one’s favour

Noom Med.

• The coaching is the actual product here and it is well built.
• Medication is included in the microdose tier rather than billed separately.

Willow.

• A single price with no membership arithmetic.

How they score

Noom Med scores higher overall at 3.5 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick Noom Med if cost is the binding constraint. Over a year the gap is about $3,000, which is real money for the same class of medication.
• Pick Willow if what it does better matters to you — a single price with no membership arithmetic.
• Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

On the board, Noom Med at $149 a month is the more defensible choice on arithmetic alone. Willow earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Noom Med and Willow.

How they sit against everyone else